BioSpace News Archive

Mylan N.V. announced that the Drug Controller General of India has approved its remdesivir 100 mg/vial for restricted emergency use in India as part of the DCGI’s accelerated approval process to address urgent, unmet needs amid the evolving coronavirus 2019 pandemic.

Vizient, Inc. has teamed up with medical suppliers to provide relief for hospitals from the strains of delivering patient care, monitoring and rehabilitation services brought on by COVID-19. The new resources and technology offerings address hospitals’ immediate and unique needs but are also designed as sustainable approaches to care delivery and improving patient satisfaction. Medtronic Care Management Services and Zimme

General Biologicals Corporation, a Taiwanese medical device company has developed the GB SARS-CoV-2 Real-Time RT-PCR : a reliable molecular testing kit for the detection of the novel coronavirus in humans.

Earnings Call to be Hosted on August 5, 2020 BILLERICA, Mass., July 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique anatomy, today announced preliminary, unaudited, revenue results for the second quarter ended June 30, 2020. Expected Q2 Summary: Total revenue of approximately $19.5

Varian (NYSE: VAR) today announced it received the “Best After-Sales Service Award for Radiotherapy Products” in the 2019 Chinese Medical Devices Industry Data and After-Sales Service Survey for the third year in a row. Varian also led in metrics of Market Share, Repurchasing Reference, and Net Promoter Score. The 1

A significant proportion of patients undergoing cancer therapy experience diarrhea.

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that it and partner OntoChem have completed the initial in silico screening process of their drug discovery program and have identified an additional specific compound, as well

AIM ImmunoTech (NYSE American:AIM), today announced that is has signed a material transfer and research agreement with Japans National Institute of Infectious Diseases (NIID) and Shionogi & Co., Ltd. (Shionogi), a leading global pharmaceutical company headquartered in Japan,

– Supports the investigation of TransCon hGH for treatment of growth hormone deficiency in the pediatric population from 6 months to less than 18 years of age – – Company on track to submit European marketing application in third quarter 2020 – – No additional studies required – COPENHAGEN, Denmark, July 06, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, tod

A-Medicare, the flagship private health services entrepreneurial enterprise of actor-producer Enzo Zelocchi, today announced launch plans for a new crypto coin as a planned element of early strategic growth integral to platform development through the remainder of 2020 and 2021.